CA2101645A1 - Procede de production d'une preparation pharmaceutique ayant un effet protecteur sur la moelle osseuse et un effet antineoplasique - Google Patents

Procede de production d'une preparation pharmaceutique ayant un effet protecteur sur la moelle osseuse et un effet antineoplasique

Info

Publication number
CA2101645A1
CA2101645A1 CA002101645A CA2101645A CA2101645A1 CA 2101645 A1 CA2101645 A1 CA 2101645A1 CA 002101645 A CA002101645 A CA 002101645A CA 2101645 A CA2101645 A CA 2101645A CA 2101645 A1 CA2101645 A1 CA 2101645A1
Authority
CA
Canada
Prior art keywords
pharmaceutical agent
free
cytostatic
effect
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002101645A
Other languages
English (en)
Inventor
Helmut Scholle
Clemens Unger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2101645A1 publication Critical patent/CA2101645A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002101645A 1991-02-22 1992-02-20 Procede de production d'une preparation pharmaceutique ayant un effet protecteur sur la moelle osseuse et un effet antineoplasique Abandoned CA2101645A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4105570A DE4105570A1 (de) 1991-02-22 1991-02-22 Verwendung eines bakterien- und eiweissfreien filtrats
DEP4105570.5 1991-02-22

Publications (1)

Publication Number Publication Date
CA2101645A1 true CA2101645A1 (fr) 1992-08-23

Family

ID=6425657

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002101645A Abandoned CA2101645A1 (fr) 1991-02-22 1992-02-20 Procede de production d'une preparation pharmaceutique ayant un effet protecteur sur la moelle osseuse et un effet antineoplasique

Country Status (7)

Country Link
EP (1) EP0572470A1 (fr)
JP (1) JPH06505016A (fr)
AU (1) AU1246692A (fr)
CA (1) CA2101645A1 (fr)
DE (2) DE4105570A1 (fr)
HU (1) HUT74576A (fr)
WO (1) WO1992014478A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4308443C2 (de) * 1993-03-17 1996-09-19 Laves Hans Georg Arzneimittel zur Behandlung von Retrovirusinfektionen
CA2378052C (fr) * 1999-08-12 2010-03-23 Katy Drieu Utilisation d'extrait de ginkgo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639830B1 (fr) * 1988-12-02 1991-03-22 Beljanski Mirko Composition antivirale et ses applications

Also Published As

Publication number Publication date
DE4290471D2 (de) 1994-04-28
DE4105570A1 (de) 1992-08-27
JPH06505016A (ja) 1994-06-09
WO1992014478A1 (fr) 1992-09-03
EP0572470A1 (fr) 1993-12-08
AU1246692A (en) 1992-09-15
HU9302387D0 (en) 1993-11-29
HUT74576A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
KR100605292B1 (ko) 신규한 오가피 및 오가피 열매, 가시오가피 다당체, 그제조방법 및 그를 활성성분으로 함유하는 항암제 조성물
KR101186898B1 (ko) 항산화 조성물
WO2004037015A1 (fr) Compositions antioxydantes
Salama et al. Experimental and therapeutic trials of amygdalin
JP4601745B2 (ja) 免疫賦活効果を相乗的に増強した製剤
KR101829637B1 (ko) 참옻나무 목심 추출물을 함유하는 항암치료 부작용에 따른 소화기능장애, 백혈구 감소증 및 골수부전증의 개선, 예방 또는 치료용 조성물
CA2101645A1 (fr) Procede de production d'une preparation pharmaceutique ayant un effet protecteur sur la moelle osseuse et un effet antineoplasique
CN107348203A (zh) 一种改善仔猪免疫力的饲料添加剂
CA2283739C (fr) Acide ascorbique agissant comme adjuvant dans le traitement de tumeurs malignes par chimiotherapie et radiotherapie
CN102451198A (zh) 一种活性防治癌症的中药配方及其制备工艺
CN101766603A (zh) 一种增强免疫力的肌肉注射给药的注射液
JP7152733B2 (ja) がん転移抑制剤
CN109045052B (zh) 用于治疗结肠癌的药物配方与应用
佐々木琢磨 et al. Antitumor activity and immunomodulatory effect of glycoprotein fraction from scallop Patinopecten yessoensis.
CN113209149A (zh) 米托蒽醌与人参总皂苷联合用药在制备治疗胃癌药物中的应用
JPH08176000A (ja) Ｃ型肝炎治療剤
JPH06199696A (ja) 制癌・抗癌剤
KR102576410B1 (ko) 바실러스 균주와 5-fu를 유효성분으로 하는 대장암 치료용 약학 조성물
KR102028383B1 (ko) 난청의 예방 또는 치료용 조성물
RU2218169C2 (ru) Комплексный способ химиолучевой и диетотерапии при лечении онкологических заболеваний
Morales et al. Prophylaxis and therapy of an experimental bladder cancer with biological response modifiers
KR100499691B1 (ko) 택솔 및 홍삼산성다당체를 포함하는 항암용 약학적 조성물
RU2311196C1 (ru) Средство "лизолакт", потенцирующее противоопухолевую активность цитотоксических препаратов
WO2021152555A1 (fr) Nouvelle immunothérapie pour des tumeurs et des cancers, et inflammation associée
CN116059322A (zh) 一种治疗和预防肿瘤的口服制剂及其制备方法

Legal Events

Date Code Title Description
FZDE Dead